FINWIRES · TerminalLIVE
FINWIRES

Update: Veradermics Shares Rise After Potential Female Hair Loss Treatment Restores Hair in Phase 2 Trial

By

(Updates with recent stock movement in headline and first paragraph.)

Veradermics (MANE) shares were up 12% in afternoon trading on Wednesday after the company said its VDPHL01 achieved rapid onset of hair growth with the majority of participants in a phase 2 clinical trial of females with mild-to-moderate pattern hair loss.

The orally-administered extended-release formulation showed improvement in hair coverage as early as the second month and "consistent treatment effect" with around 88.9% dosed once a day and 90.0% with those dosed twice a day reporting "improved" or "much improved" results after six months, the company said.

VDPHL01 also showed a "favorable" safety and tolerability profile consistent with previous trials, the company said.

Veradermics is planning a phase 2/3 clinical trial with results expected in H1 2027, the company said.

Price: $123.39, Change: $+13.22, Percent Change: +12.00%

Related Articles

Wire

Rio Tinto Group's Q2 Update Shows Production in Line With Consensus, Says Jefferies

Rio Tinto Group (ASX:RIO) reported second quarter production exceeding expectations for Pilbara iron ore production and shipments, while performance across its other major operating assets was also broadly in line with market forecasts, according to a Wednesday Jefferies note.The investment firm added that the company has reduced unit cost guidance in copper to $0.30 to $0.50 per pound from $0.65 to $0.75 per pound due to higher gold prices and operational improvement initiatives."While mostly an uneventful report from Rio, the [quarter-on-quarter] rebound in volumes at certain assets in 2Q is encouraging," the investment firm said.Jefferies kept a hold rating on Rio Tinto with a price target of AU$187.The company's shares rose past 1% in recent Wednesday trade.

ASX:RIO
Wire

Copa Holdings Reports Higher June Passenger Capacity, Traffic

Copa Holdings (CPA) said its preliminary June passenger capacity, measured as available seat miles, increased 16% from a year earlier.Passenger traffic, measured as revenue passenger miles, rose 13%, the company said Tuesday in a statement.Copa shares gained 3.1% in after-hours trading.

$CPA
Wire

Phoenix Education Partners Fiscal Q3 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

Phoenix Education Partners (PXED) reported fiscal Q3 adjusted earnings late Tuesday of $1.43 per diluted share, down from $1.57 a year earlier.Analysts polled by FactSet expected $1.32.Revenue in the three months ended May 31 rose to $271.8 million from $271.7 million a year earlier. Analysts expected $271.2 million.Phoenix expects full-year net revenue of $1.02 billion to $1.025 billion. Analysts expect $1.026 billion.The company's shares fell 11% in after-hours trading.

$PXED